Beam Therapeutics Inc. (BEAM)
Biological Products, (No Diagnostic Substances)
Latest Price
$25.52
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
11.28
P/B Ratio
2.26
Institutional Ownership
90.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| FMR LLC | 12.45M | $296.0M | 12.12% | +543.1K | 2026-03-31 |
| ARK Investment Management LLC | 12.13M | $289.0M | 11.81% | -333.8K | 2026-03-31 |
| BlackRock, Inc. | 8.49M | $202.0M | 8.26% | +37.4K | 2026-03-31 |
| STATE STREET CORP | 5.70M | $135.0M | 5.55% | +470.7K | 2026-03-31 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4.57M | $108.0M | 4.45% | -- | 2026-03-31 |
| ARCH Venture Management, LLC | 4.54M | $108.0M | 4.42% | -- | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.38M | $104.0M | 4.26% | -- | 2026-03-31 |
| Sumitomo Mitsui Trust Group, Inc. | 3.83M | $91.0M | 3.72% | -583.7K | 2026-03-31 |
| Kynam Capital Management, LP | 3.68M | $87.0M | 3.58% | +305.0K | 2026-03-31 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2.71M | $64.0M | 2.64% | -17.1K | 2026-03-31 |